Sirtuins

Sirtuin inhibitors and activators target the seven mammalian sirtuins, a family of protein deacetylases. Yeast silent information regulator 2 (Sir2), the founding member, is a histone deacetylase that requires nicotinamide adenine dinucleotide (NAD+). Human sirtuins (SIRT1 to SIRT7) differ in location, with SIRT1 mainly nuclear, SIRT2 mainly cytoplasmic and SIRT3 to SIRT5 in mitochondria. Selisistat, also known as EX-527, inhibits SIRT1, and SirReal2 selectively inhibits SIRT2. SRT1720 HCl and SRT2104 are described as synthetic SIRT1 activators. Nicotinamide, a product of the sirtuin reaction, inhibits sirtuin activity, while nicotinamide riboside is a precursor of NAD+.

Items 26-36 of 36

  • Nicotinamide riboside
    Cat. No.
    A56989

    Nicotinamide riboside

    Nicotinamide riboside is an orally active NAD+ precursor that functions as an activator of SIRT1 and SIRT3. This compound elevates NAD+ levels, enhances oxidative metabolism, and provides protective effects against metabolic abnormalities induced by high-fat diets. Additionally, nicotinamide riboside has been shown to mitigate cognitive decline in transgenic mouse models of Alzheimer’s disease, making it a valuable reagent for research in metabolism and neurodegenerative disorders.

    5 mg
    $40.00
    200 mg
    $185.00
    All 2 sizes
  • CL5D
    Cat. No.
    A56995

    CL5D

    CL5D is a selective activator of the protein deacetylase SIRT6, enhancing its deacetylation activity and catalytic efficiency. By promoting conformational changes, specifically involving the Arg-65 residue, CL5D serves as a valuable tool for investigating the regulatory mechanisms of SIRT6. This compound is applicable in research areas related to metabolism, DNA repair, and aging, facilitating a deeper understanding of SIRT6’s biological functions.

    Out of stock

    All 3 sizes
  • F0911-7667
    Cat. No.
    A56996

    F0911-7667

    F0911-7667 is a potent activator of SIRT1, promoting autophagic cell death in U87MG and T98G glioblastoma cells through the activation of the AMPK-mTOR-ULK complex. Additionally, this compound has demonstrated its ability to reduce p53 acetylation in IMR32 neuroblastoma cells, providing protective effects against cell death induced by amyloid-beta (Aβ) fragments. Its unique mechanism and biological activities make it valuable for research in cancer and neurodegenerative disease models.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • DCHC
    Cat. No.
    A57004

    DCHC

    DCHC is a specific activator of SIRT1, enhancing its enzymatic activity without increasing SIRT1 expression levels. This compound is particularly useful in studies investigating mitochondrial damage and dysfunction, offering insights into metabolic regulation and cellular stress responses. DCHC's ability to activate SIRT1 makes it a valuable tool for exploring the roles of sirtuins in cellular health and disease.

    Out of stock

    All 3 sizes
  • SIRT6 activator 2
    Cat. No.
    A57010

    SIRT6 activator 2

    SIRT6 activator 2 is a specific activator of sirtuin 6, known for its anti-lipid accumulation properties. This compound effectively downregulates key transcription factors LXR and SREBP-1c, along with their downstream target genes involved in lipogenesis. SIRT6 activator 2 is valuable for research focused on lipid metabolism and associated diseases, enabling the exploration of therapeutic strategies targeting metabolic disorders.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • Sirtuin modulator 5
    Cat. No.
    A57021

    Sirtuin modulator 5

    Sirtuin Modulator 5 is a potent activator of SIRT1, demonstrating a DC50 value of less than 50 μM. This compound enhances cellular lifespan and facilitates research into various age-related and stress-related diseases, including diabetes, obesity, neurodegenerative disorders, cardiovascular diseases, blood clotting disorders, inflammation, and cancer. Additionally, Sirtuin Modulator 5 may promote increased mitochondrial activity, making it a valuable tool in the study of metabolic and age-related diseases.

    5 mg
    $75.00
    10 mg
    $110.00
    All 6 sizes
  • SRT3657
    Cat. No.
    A57023

    SRT3657

    SRT3657 is a selective activator of SIRT1, exhibiting properties that enhance neuronal resilience. Its brain-permeable nature allows for effective modulation of SIRT1 activity, contributing to neuroprotection. This compound is valuable for research applications aimed at understanding neurodegenerative diseases and exploring potential therapeutic strategies.

    25 mg
    $1,655.00
    50 mg
    $2,115.00
    All 3 sizes
  • SRTCX1002
    Cat. No.
    A57026

    SRTCX1002

    SRTCX1002 is a selective activator of the SIRT1 enzyme, functioning primarily through the promotion of p65 deacetylation, which subsequently inhibits NF-κB activity. This compound effectively suppresses inflammatory responses, demonstrated by its ability to inhibit stimuli-induced NF-κB transcriptional activation and reduce LPS-induced TNFα secretion, with IC50 values of 0.71 µM and 7.58 µM, respectively. SRTCX1002 serves as a valuable reagent for research focused on inflammation and related signaling pathways.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • SRTCX1003
    Cat. No.
    A57029

    SRTCX1003

    SRTCX1003 is an orally active SIRT1 activator that enhances SIRT1 activity, leading to the modulation of various biological processes. This compound has been shown to suppress inflammatory responses, making it a valuable tool for research related to inflammation and metabolic disorders. Its application in studies focused on SIRT1-mediated pathways provides insights into potential therapeutic approaches for a range of diseases.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • 3β,6α,12β-Dammar-E-20(22)-ene-3,6,12,25-tetraol
    Cat. No.
    A57037

    3β,6α,12β-Dammar-E-20(22)-ene-3,6,12,25-tetraol

    3β,6α,12β-Dammar-E-20(22)-ene-3,6,12,25-tetraol is a potent SIRT1 activator that enhances SIRT1 activity significantly. This compound has demonstrated anti-tumor activity, making it a valuable tool for research in cancer biology and therapeutic interventions targeting SIRT1 modulation. Its role in promoting cellular metabolism and longevity pathways further supports its use in studies related to aging and metabolic disorders.

    Out of stock

    All 3 sizes
  • Nicotinamide riboside (triflate)
    Cat. No.
    A57041

    Nicotinamide riboside (triflate)

    Nicotinamide riboside (triflate) is a potent activator of the SIRT1 and SIRT3 pathways, functioning as an orally active precursor to NAD+. This compound significantly elevates NAD+ levels, thereby enhancing oxidative metabolism and providing protective effects against metabolic disturbances triggered by high-fat diets. Additionally, it has demonstrated neuroprotective properties, as evidenced by its ability to mitigate cognitive decline in transgenic mouse models of Alzheimer’s disease, making it valuable for research in metabolic health and neurodegenerative disorders.

    25 mg
    $3,780.00
    All 1 sizes

Items 26-36 of 36

Added to your cart

View Cart Checkout

    Loading...